Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$38,714,004
+$11,897,191 QoQ
Shares Held
32,277
+10.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#620
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. LLY ranks #1 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
32,277 | $38,714,004 | |
| 2 | JNJ |
Johnson & Johnson
|
114,657 | $29,119,437 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
320,925 | $18,491,698 | |
| 4 | MRK |
Merck & Co., Inc.
|
140,968 | $18,114,387 | |
| 5 | ABBV |
AbbVie Inc.
|
65,660 | $16,522,681 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
104,200 | $13,164,627 | |
| 7 | PFE |
Pfizer Inc
|
411,666 | $9,912,916 | |
| 8 | AMGN |
Amgen Inc
|
26,885 | $9,735,596 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,714,004 | 32,277 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $26,816,813 | 29,156 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $29,868,583 | 27,793 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,333,541 | 21,407 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $13,756,365 | 17,647 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $10,175,210 | 12,320 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,209,456 | 6,748 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,794,933 | 6,541 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,936,131 | 5,452 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,042,601 | 3,911 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,217,427 | 3,804 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,105,549 | 3,920 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,191,209 | 2,540 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $988,706 | 2,879 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $828,627 | 2,265 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $772,159 | 2,388 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $782,366 | 2,413 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $753,153 | 2,630 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $896,886 | 3,247 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $707,244 | 3,061 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $810,435 | 3,531 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $869,460 | 4,654 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $269,975 | 1,599 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $76,082 | 514 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $83,075 | 506 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $73,382 | 529 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||